PHARMACEUTICAL COMPOSITIONS AND METHOD UTILIZING PYRIDOSTIGMINE AND A NK-1 ANTAGONIST FOR TREATING MYASTHENIA GRAVIS

• 收藏
• 分享

专利权人:

DAS-MG; Inc.

发明人:

Kathleen Clarence-Smith

申请号：

US16752590

公开号：

US20200155530A1

申请日:

2020.01.24

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention describes the use of a NK1-antagonist, in constant combination with pyridostigmine, to facilitate the treatment of a patient suffering from myasthenia gravis by providing a therapeutically effective pyridostigmine bromide daily dose without the dose-limiting gastro-intestinal adverse effects.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/